- SBI Life’s net income for the second quarter was 5.29 billion rupees, marking a 39% increase year over year but missing the estimated 7.3 billion rupees.
- Total costs for the company rose by 40% year over year, amounting to 395.5 billion rupees.
- The net premium income saw a slight increase of 1.1% year over year to 202.7 billion rupees.
- First Year Premium revenue grew by 6.3% year over year, reaching 49.2 billion rupees.
- Renewal Premium experienced a significant increase of 16% year over year, totaling 117.2 billion rupees.
- Single Premium revenue, however, declined by 30% year over year to 37.8 billion rupees.
- The company’s stock received 33 buy recommendations, 1 hold, and 0 sell recommendations from analysts.
A look at SBI Life Insurance Co Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Smartkarma Smart Scores indicate a promising long-term outlook for SBI Life Insurance Co Ltd. With a strong resilience score of 5, the company displays robustness and stability in the face of challenges. Momentum is also high at 4, pointing towards positive growth trends and market momentum. Additionally, the growth score of 3 suggests potential for expansion and development in the future.
Although the value and dividend scores are moderate at 2 each, they indicate steady performance in terms of value and dividend distributions. Overall, SBI Life Insurance Co Ltd appears well-positioned to capitalize on its strengths in resilience, momentum, and growth to drive future success in the financial services sector in India.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
